—
—
In Stock
Vasoactive Intestinal Peptide (VIP) is a naturally occurring neuropeptide found in the body, primarily in the brain, lungs, and digestive tract. It plays a crucial role in regulating smooth muscle relaxation, blood flow, electrolyte secretion, and inflammatory responses. As a therapeutic peptide, synthetic VIP is being explored for its potential in treating a range of inflammatory, autoimmune, and neurodegenerative conditions. How It Works VIP binds to specific VPAC1 and VPAC2 receptors on target cells. This activation triggers intracellular signaling that promotes: - Smooth muscle relaxation in the respiratory, vascular, and gastrointestinal systems. - Anti-inflammatory effects by reducing pro-inflammatory cytokines. - Neuroprotection through modulation of immune cell activity and enhancement of neuronal survival. - Immune regulation by balancing Th1/Th2 responses. Potential Benefits Research suggests VIP peptide may help in: - Respiratory Health – Supporting lung function in conditions like asthma, COPD, pulmonary hypertension, and sarcoidosis. - Neuroprotection – Possible benefits in Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. - Immune Modulation – Helping regulate immune overactivity in autoimmune diseases such as multiple sclerosis and inflammatory bowel disease. - Gut Health – Supporting intestinal barrier integrity and reducing inflammation in disorders like Crohn’s disease or ulcerative colitis. - Vascular Support – Enhancing blood flow and reducing vascular inflammation. Administration - Typically administered via subcutaneous injection. - Dosage and treatment duration vary depending on the individual’s condition and medical supervision. - Often used in research and clinical trial settings rather than standard prescription use. Side Effects & Considerations - Generally well-tolerated in research settings, but potential side effects may include flushing, headache, low blood pressure, or mild gastrointestinal discomfort. - Not FDA-approved for general medical use; most applications remain experimental. - Should be used only under the guidance of a qualified healthcare professional. Current Research VIP is being actively studied for: - Chronic Inflammatory Response Syndrome (CIRS) linked to mold and biotoxin exposure. - Pulmonary arterial hypertension therapy. - Neurodegenerative and inflammatory disorders. - Its role as an immunomodulator in viral and bacterial infections. 💡 Key Takeaway: VIP peptide is a promising therapeutic agent with potent anti-inflammatory, neuroprotective, and immune-balancing properties. While early results are encouraging, its use remains primarily in research contexts, and more large-scale human trials are needed before it becomes widely available for clinical treatment.
